Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-16, Stock:LLY, The news for the past five days is as follows:
2018-10-09: NEWS1: 4 Reasons to Be Wary of This Animal Health IPO.NEWS2: 4 Reasons to Be Wary of This Animal Health IPO.NEWS3: Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes.NEWS4: 4 Reasons to Be Wary of This Animal Health IPO.NEWS5: A Look at Novartis’s Valuation on October 9.NEWS6: Assessing Novartis’s Performance in October So Far.NEWS7: 5 Companies Hit 52-Week Highs.NEWS8: A Walk-Through of Eli Lilly’s Alzheimer’s Disease Portfolio.
2018-10-10: NEWS1: The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares.NEWS2: New analysis estimates the positive impact of Jardiance® on life expectancy in adults with type 2 diabetes and established cardiovascular disease.
2018-10-11: NEWS1: Investor Insights: Teva Pharmaceutical’s Valuation Multiples.NEWS2: Noteworthy Thursday Option Activity: MAR, LLY, FIT.NEWS3: Noteworthy Thursday Option Activity: MAR, LLY, FIT.NEWS4: Incyte's Jakafi Demand Strong, Label Expansion to Boost Sales.NEWS5: Incyte's Jakafi Demand Strong, Label Expansion to Boost Sales.NEWS6: Here’s why you should expect more ‘beats’ during this earnings season.
2018-10-12: NEWS1: A Financial Overview of Bausch Health in October.NEWS2: How Analysts View Bausch Health in October.NEWS3: 3 Large-Cap Pharma Stocks Performing Better Than Industry.NEWS4: 3 Large-Cap Pharma Stocks Performing Better Than Industry.NEWS5: Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal.NEWS6: Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal.NEWS7: This is Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS8: This is Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS9: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS10: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS11: 3 Large-Cap Pharma Stocks Performing Better Than Industry.NEWS12: Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?.NEWS13: This is Why Eli Lilly (LLY) is a Great Dividend Stock.NEWS14: Lilly and Metastatic Breast Cancer Advocates Launch Thriver Movement to Elevate Understanding of the Daily Impact of the Disease, Encourage Public to do More for MBC.
2018-10-15: NEWS1: Daily Dividend Report: LLY, NEE, SO, VMC, LNT.NEWS2: Daily Dividend Report: LLY, NEE, SO, VMC, LNT.NEWS3: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS4: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS5: What’s Expected for Merck’s Q3 2018 Earnings.NEWS6: Lilly Declares Fourth-Quarter 2018 Dividend.NEWS7: 3 Healthcare Stocks to Buy Amid the Carnage.NEWS8: Eli Lilly’s IPO of Animal Health Company Is Getting ‘Ahead of Itself,’ Goldman Says.NEWS9: Drugmakers will soon talk about price in ads — but not as explicitly as Trump administration wants.NEWS10: Novartis’ Estimates and Recommendations on October 12.NEWS11: Novartis: What to Expect from Q3 Earnings on October 18.NEWS12: New Data Showcasing Lilly's Growing Commitment in Rheumatology to be Featured at the ACR/ARHP Annual Meeting.

Answer: Rise